Dr Reddy’s expects first lot of Russia’s COVID-19 vaccine Sputnik V by May end
Once available, SputnikV will be the third vaccine to be used in India against coronavirus.
By PTI| Posted by Minhaj Adnan | Updated: 27th April 2021 3:17 pm IST
Hyderabad: Dr Reddy’s Laboratories, which has received approval from the Indian drug regulator for restricted emergency use of COVID-19 vaccineSputnik V,on Tuesday said it expects the first lot of stock from Russian Direct Investment Fund by May end.
In September 2020, Dr Reddys and RDIF entered into a partnership to conduct clinical trials of SputnikV, developed by the Gamaleya National Research Institute of Epidemiology and Microbiology and the rights for distribution of the first 100 million doses in India.
When will Sputnik V vaccine arrive in India? Know what Dr Reddy's has to say
indiatvnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatvnews.com Daily Mail and Mail on Sunday newspapers.
sputnik v vaccine: Dr Reddy's expects first lot of Russia's COVID-19 vaccine Sputnik V by May end
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Min
Dear Chairman Wyden, Chairman Neal, Ranking Member Crapo, and Ranking Member Brady:
On behalf of the undersigned taxpayer, free-market, and consumer advocacy organizations, we ask you to prioritize and pass a number of tax relief measures this year that will aid in America’s economic recovery from the COVID-19 pandemic. Pro-growth tax policy that boosts GDP, jobs, and wages should be a legislative priority at any time but has taken on an added importance as policymakers look to help businesses and workers return to the economic gains of the pre-COVID U.S. economy.
Specifically, we hope your Committees and Congressional leadership will prioritize the following this year: